PGAM1 and hepatocellular carcinoma: In a model of hepatocellular carcinoma (HCC), Pgam1 is reported to be a novel immunometabolic target and inhibition of Pgam1 promotes HCC ferroptosis through inducing CD8+ T-cell infiltration 45, suggesting a linkage between Pgam1 and inflammation.